Yang Yang-Ming, Sehgal Pravin B
Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY 10595, USA.
Department of Medicine, New York Medical College, Valhalla, NY 10595, USA.
Int J Endocrinol. 2018 Jul 24;2018:3473105. doi: 10.1155/2018/3473105. eCollection 2018.
The "estrogen paradox" in pulmonary arterial hypertension (PAH) refers to observations that while there is a higher incidence of idiopathic PAH in women, rodent models of PAH show male dominance and estrogens are protective. To explain these differences, we previously proposed the neuroendocrine-STAT5-BCL6 hypothesis anchored in the sex-biased and species-specific patterns of growth hormone (GH) secretion by the pituitary, the targeting of the hypothalamus by estrogens to feminize GH secretion patterns, and the role of the transcription factors STAT5a/b and BCL6 as downstream mediators of this patterned GH-driven sex bias. As a test of this hypothesis, we previously reported that vascular smooth muscle cell- (SMC-) specific deletion of the locus abrogated the male-dominant sex bias in the chronic hypoxia model of PAH in mice. In the present study, we confirmed reduced BCL6 expression in pulmonary arterial (PA) segments in both male and female SMC: mice. In order to test the proposed contribution of BCL6 to sex bias in PAH, we developed mice with SMC-specific deletion of by crossing SM22-Cre mice with mice and investigated sex bias in these mutant mice in the chronic hypoxia model of PAH. We observed that the male-bias observed in wild-type- (-) SM22-positive mice was abrogated in the SMC: knockouts-both males and females showed equivalent enhancement of indices of PAH. The new data confirm BCL6 as a contributor to the sex-bias phenotype observed in hypoxic PAH in mice and support the neuroendocrine-STAT5-BCL6 hypothesis of sex bias in this experimental model of vascular disease.
肺动脉高压(PAH)中的“雌激素悖论”指的是以下观察结果:虽然特发性PAH在女性中的发病率较高,但PAH的啮齿动物模型显示雄性占优势且雌激素具有保护作用。为了解释这些差异,我们之前提出了神经内分泌-STAT5-BCL6假说,该假说基于垂体生长激素(GH)分泌的性别差异和物种特异性模式、雌激素对下丘脑的靶向作用以使GH分泌模式女性化,以及转录因子STAT5a/b和BCL6作为这种由GH驱动的模式化性别差异的下游介质的作用。作为对该假说的验证,我们之前报道在小鼠PAH慢性缺氧模型中,血管平滑肌细胞(SMC)特异性缺失该位点可消除雄性占主导的性别差异。在本研究中,我们证实了雄性和雌性SMC:小鼠的肺动脉(PA)段中BCL6表达均降低。为了检验所提出的BCL6对PAH性别差异的作用,我们通过将SM22-Cre小鼠与小鼠杂交,培育出SMC特异性缺失的小鼠,并在PAH慢性缺氧模型中研究了这些突变小鼠的性别差异。我们观察到,在野生型-(-)SM22阳性小鼠中观察到的雄性偏向在SMC:基因敲除小鼠中被消除——雄性和雌性小鼠的PAH指标均有同等程度的增强。新数据证实BCL6是小鼠缺氧性PAH中观察到的性别偏表型的一个促成因素,并支持了这种血管疾病实验模型中性别差异的神经内分泌-STAT5-BCL6假说。